Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edaravone dexborneol PET/MRI neuroinflammation study in acute ischemic stroke
ChiCTR2100048153Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Jinan University
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of edaravone dexborneol in ischemic stroke (2 arms), sponsored by First Affiliated Hospital of Jinan University. Primary endpoint: PET/CT normalized uptake value. Started May 2021; status: recruiting.
02
Drugs
edaravone dexborneol
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2100048153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048153.